Drusen
Showing 1 - 25 of 146
Verification of Candidate Genes Responsible for Optic Disc
Not yet recruiting
- Optic Disk Drusen
- Whole exome sequencing
- (no location specified)
Feb 20, 2023
Macular Degeneration, Retinal Drusen Trial in Palo Alto (Pascal Retinal Laser Photocoagulator)
Completed
- Macular Degeneration
- Retinal Drusen
- Pascal Retinal Laser Photocoagulator
-
Palo Alto, CaliforniaByers Eye Institute at Stanford University
Oct 13, 2021
Age-Related Macular Degeneration Trial in Worldwide (Yellow and red light emitting diode photobiomodulation (Eye Light,
Recruiting
- Age-Related Macular Degeneration
- Yellow and red light emitting diode photobiomodulation (Eye Light, Espansione Group, Bologna, Italy)
- Sham Mask
-
Paris, France
- +6 more
Sep 14, 2023
AMD, Soft Drusen, Reticular Pseudodrusen Trial in Barcelona (Postbotics and Vitamins, Vitamins)
Recruiting
- AMD
- +4 more
- Postbotics and Vitamins
- Vitamins
-
Barcelona, SpainInstitut de la Macula
Sep 14, 2021
Age Related Macular Degeneration Trial in Clermont-Ferrand (T7082)
Completed
- Age Related Macular Degeneration
- T7082
-
Clermont-Ferrand, FranceWilfried Roquet
Feb 14, 2022
Reticular Pseudodrusen (RPD), Age-Related Macular Degeneration Trial run by the NEI (Vitamin A Palmitate)
Recruiting
- Reticular Pseudodrusen (RPD)
- Age-Related Macular Degeneration
- Vitamin A Palmitate
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 12, 2022
Tinnitus, Subjective, Tinnitus, Bilateral, Antioxidant Therapy Trial in Guadalajara (Drusen Mega®, Adepsique®, Placebo)
Recruiting
- Tinnitus, Subjective
- +5 more
- Drusen Mega®
- +2 more
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics,
Dec 13, 2022
Drusen Trial in Wenzhou (laser treatment)
Unknown status
- Drusen
- laser treatment
-
Wenzhou, Zhejiang, ChinaThe eye of Wenzhou Medical University
Feb 23, 2021
AMD Between Systemic Lupus Erythematosus With and Without
Completed
- Lupus Erythematosus
- +2 more
- Blood test
-
Paris, FranceFondation ophtalmologique Adolphe de Rothschild
May 21, 2021
Diabetic Retinopathy Trial in Guadalajara (Combined antioxidant therapy, Placebo)
Completed
- Diabetic Retinopathy
- Combined antioxidant therapy
- Placebo
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics,
Mar 21, 2022
Diabetic Retinopathy, Oxidative Stress, Diabetes Trial in Guadalajara (Combined antioxidant therapy, Placebo)
Completed
- Diabetic Retinopathy
- +2 more
- Combined antioxidant therapy
- Placebo
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics,
Mar 21, 2022
Glaucoma, Glaucoma Suspect, Diabetic Retinopathy Trial in Philadelphia (Free Eye Screenings, Enhanced Intervention, Usual Care)
Completed
- Glaucoma
- +12 more
- Free Eye Screenings
- +2 more
-
Philadelphia, PennsylvaniaWills Eye Glaucoma Service
Aug 19, 2022
Age Related Macular Degeneration Trial in Chicago (Longvida curcumin, )
Recruiting
- Age Related Macular Degeneration
- Longvida curcumin
- placebo
-
Chicago, IllinoisIllinois eye and ear infirmary
May 29, 2021
NA-AION Risk Factors: New Perspectives
Recruiting
- Non-arteritic Ischemic Optic Neuropathy
- Optic Disk Drusen
-
Palo Alto, California
- +19 more
Mar 22, 2022
Macular Degeneration, Age Related, Cataract Trial (NGenuity)
Not yet recruiting
- Macular Degeneration, Age Related
- Cataract
- NGenuity
- (no location specified)
Aug 3, 2023
Age-related Macular Degeneration Trial in Boston (Atorvastatin 80mg)
Recruiting
- Age-related Macular Degeneration
- Atorvastatin 80mg
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Oct 7, 2021
AMD Ryan Initiative Study (ARIS)
Completed
- Age-Related Macular Degeneration
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 30, 2023
Systematic Imaging Examination in ODD
Unknown status
- Optic Disk Drusen
-
Guangzhou, Guangdong, ChinaThe third affiliated hospital of Sun Yat-sen University
May 21, 2019
Age-Related Macular Degeneration, Geographic Atrophy, Reticular Pseudodrusen Trial in Milan (Subthreshold 577 nm yellow
Completed
- Age-Related Macular Degeneration
- +2 more
- Subthreshold 577 nm yellow wavelength laser photo-coagulator
-
Milan, MI, ItalyOspedale San Raffaele
Feb 2, 2020
A Collaborative Resource of Heidelberg Multimodal Imaging of
Not yet recruiting
- Age Related Macular Degeneration
- +3 more
- Collection of both retrospective and prospective data collection in 3 visits.
- (no location specified)
Jan 16, 2023
Dry Age-related Macular Degeneration Trial (QA102/Placebo, QA102, Placebo)
Not yet recruiting
- Dry Age-related Macular Degeneration
- QA102/Placebo
- +2 more
- (no location specified)
Sep 8, 2022
Intermediate Age-Related Macular Degeneration Trial in Peking (QA108 granules, QA108 granules )
Recruiting
- Intermediate Age-Related Macular Degeneration
- QA108 granules
- QA108 granules placebo
-
Peking, ChinaPeking Union Medical College Hospital (PUMCH)
Sep 28, 2022
Study of Dark Adaptation in Age-Related Macular Degeneration
Recruiting
- Age-Related Macular Degeneration
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Retinal Drusen, Age-related Macular Degeneration, Macular Degeneration Trial in Austin (Lumega-Z, AREDS2)
Completed
- Retinal Drusen
- +2 more
- Lumega-Z
- AREDS2
-
Austin, TexasEye Clinic of Austin
May 9, 2019
Macular Membrane Peeling Associated With Significant Macular
Completed
- Epiretinal Membrane
- +2 more
- pars plana vitrectomy with membrane peeling
-
Chemnitz, Saxony, GermanyKlinikum Chemnitz, Ophthalmology Department
Apr 29, 2019